Jenny Goudemand

Acquired type II von Willebrand's disease: demonstration of a complexed inhibitor of the von Willebrand factor‐platelet interaction and response to treatment

B. Jude, J. Goudemand, B. Samor, 1988, British journal of haematology.

Conformational changes in the D' domain of von Willebrand factor induced by CYS 25 and CYS 95 mutations lead to factor VIII binding defect and multimeric impairment.

J. Goudemand, É. Fressinaud, C. Mazurier, 2000, Blood.

Functional mapping of anti-factor IX inhibitors developed in patients with severe hemophilia B.

O. Christophe, P. Lenting, J. Goudemand, 2001, Blood.